Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

CNTB Connect Biopharma Holdings Inc

0,97

-0,01 (-1,02%)

Nach Börsenschluss

Zuletzt aktualisiert: 22:30:00

Verzögert um 15 Minuten

Annual and Transition Report (foreign Private Issuer) (20-f)

This article is 7Mb in size. Click here to view

Connect Biopharma (NASDAQ:CNTB)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Connect Biopharma Charts.

Connect Biopharma (NASDAQ:CNTB)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Connect Biopharma Charts.

News Connect Biopharma Holdings Ltd

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Montag 23 Dezember 2024 (1 Monat vor) • Edgar (US Regulatory)

Attovia Therapeutics Appoints Chief Financial Officer
Dienstag 15 Oktober 2024 (3 Monate vor) • GlobeNewswire Inc.

Connect Biopharma to Participate in the Cantor Fitzgerald Global Healthcare Conference 2024
Dienstag 10 September 2024 (5 Monate vor) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Freitag 6 September 2024 (5 Monate vor) • Edgar (US Regulatory)

Connect Biopharma Reports First Half 2024 Financial Results and Provides Business Update
Donnerstag 5 September 2024 (5 Monate vor) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Freitag 2 August 2024 (6 Monate vor) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Mittwoch 12 Juni 2024 (8 Monate vor) • Edgar (US Regulatory)

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Mittwoch 28 Februar 2024 (11 Monate vor) • Edgar (US Regulatory)

Form SC 13D - General statement of acquisition of beneficial ownership
Dienstag 13 Februar 2024 (12 Monate vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Dienstag 13 Februar 2024 (12 Monate vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Dienstag 13 Februar 2024 (12 Monate vor) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Montag 12 Februar 2024 (12 Monate vor) • Edgar (US Regulatory)

Weitere Connect Biopharma Holdings Ltd News-Artikel

Financial Select Sector

Deutsche Lufthansa

Invesco QQQ Trust Series 1

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen